by Kall Kwik WGC | Oct 17, 2020 | Free Library
October, 2020 SMM-219 Bayer’s Drop of the Future With the rising importance of the ‘patient payer,’ the Bayer/One Drop business model brings together capabilities that neither firm possesses in full. Not only did this confirm...
by Kall Kwik WGC | Sep 16, 2020 | Free Library
September, 2020 SMM-217 Stop That! Everywhere in our industry, I see thinking that works well for scientists. Questions like ‘how will factor x impact on situation y?’ This way of thinking has its place, especially where confounding factors can...
by Kall Kwik WGC | Jul 31, 2020 | Free Library
July, 2020 SMM-216 Socially Distanced Strategising The new normal can improve how you create strategy
by Kall Kwik WGC | Jun 30, 2020 | Free Library
June, 2020 SMM-215 We’ve got this! Changes in the social and technological environment of the life sciences industry over the last century or so have varied greatly. But they had one thing in common: they all made the embedded, comfortable...
by Kall Kwik WGC | Jun 9, 2020 | Free Library
May, 2020 SMM-213 The Big Issue On any working day, your CEO may face a thousand issues. But, from the C-suite, the elephant in the room is always bicongruence. This article explains how we tame it.
